KBLBOTCPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)Fiscal year ends December 31
Kraig Biocraft Laboratories, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.08−0.00 (-4.70%)
Close on Oct 19, 2026
- Market cap
- $90.05M
- P/E (TTM)
- –
- Dividend yield
- –
Kraig Biocraft Laboratories statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) companies for comparison
Valuation
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Market Cap | $90.45M | $197.05M |
| Enterprise Value | $87.06M | $106.56M |
Income (trailing twelve months)
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Operating Income | -$3.69M | -$21.44M |
| Pretax Income | -$4.15M | -$14.45M |
| Net Income | -$4.15M | -$22.46M |
| EBITDA | -$3.69M | -$16.91M |
| EPS (Diluted) | $0.00 | -$0.83 |
Returns
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Return on Assets (ROA) | -141.5% | -41.0% |
Balance sheet
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.39M | $62.42M |
| Net Cash (Debt) | $3.39M | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | -$6.75M | $48.79M |
| Book Value Per Share | -$0.01 | $1.36 |
| Tangible Book Value | -$6.75M | $23.06M |
| Working Capital | -$7.33M | $75.77M |
Financial position
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Current Ratio | 0.33 | 3.30 |
| Quick Ratio | 0.31 | 2.39 |
| Interest Coverage | -6.27 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.04M | -$12.35M |
| Capital Expenditures | -$44.34K | -$1.06M |
| Free Cash Flow | -$2.08M | -$20.28M |
| FCF Per Share | -$0.00 | -$0.41 |
Efficiency
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Profits Per Employee | -$592.78K | -$732.08K |
| Employee Count | 7 | 73 |
Dividends and yields
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Earnings Yield | -4.59% | -21.2% |
| FCF Yield | -2.30% | -7.64% |
Shares
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Shares Outstanding | 1,115,330,000 | 59,128,900 |
| Shares Change (YoY) | 4.42% | 11.1% |
| Float | 907,963,000 | 48,744,500 |
| Shares Held by Insiders | 18.6% | 11.8% |
| Shares Held by Institutions | 0.00% | 59.4% |
Scores
| Measure | Kraig Biocraft Laboratories | Industry median |
|---|---|---|
| Altman Z-Score | -19.17 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Kraig Biocraft Laboratories's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.